Developing evidence-based standards for the administration of oral anticancer medicines
Cancer Nursing Practice · 04.09.2023 · 22 (5) · 29-35
DOI: 10.7748/cnp.2022.e1828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Nursing Practice, erschienen am 04.09.2023. Verfasst von Janice Patricia Richmond und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Cancer treatments have undergone a paradigm shift with the development and rapid growth of the use of oral anticancer treatment, particularly within the past ten years. Responsibility for administration of oral anticancer medicines has largely been devolved from the oncology team to the patient and their caregivers. However, there are longstanding safety concerns about people receiving oral anticancer medicines, therefore patient management and safety is of paramount importance. The authors reviewed the evidence and guidelines on administration of oral anticancer medicines, which encompasses patient management, then formulated new standards for clinical practice, which are reported in the article.
Zitieren
APA
Richmond, J. P., Kelly, M. G., Murphy, P. J., Murphy, A. W., & Johnston, A. (2023). Developing evidence-based standards for the administration of oral anticancer medicines. Cancer Nursing Practice, 22(5), 29-35. https://doi.org/10.7748/cnp.2022.e1828
Vancouver
Richmond JP, Kelly MG, Murphy PJ, Murphy AW, Johnston A. Developing evidence-based standards for the administration of oral anticancer medicines. Cancer Nursing Practice. 2023;22(5):29-35. doi:10.7748/cnp.2022.e1828
BibTeX
@article{Richmond2023,
author = {Richmond, Janice Patricia and Kelly, Mary Grace and Murphy, Patrick Jeremiah and Murphy, Andrew William and Johnston, Alison},
title = {Developing evidence-based standards for the administration of oral anticancer medicines},
journal = {Cancer Nursing Practice},
year = {2023},
volume = {22},
number = {5},
pages = {29--35},
doi = {10.7748/cnp.2022.e1828}
}
EUVIMED